However, another recent large-scale sequencing study of cell lines from 38 KC (LSL-KrasG12D/+; Ptf1a-Cre) mice highlighted the contribution of mutant Kras dosage to tumor progression and metastatic potential, thereby providing some of the first evidence of functionally significant genomic events that occur beyond the conditionally activated alleles23. Here, KRAS is linked to neoplasm.